Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.

The following has been adapted from an article posted by the IU Fairbanks School of Public Health. 

Regenstrief research scientist Nir Menachemi, PhD, MPH, received the Indiana Healthcare Executives Network (iHEN) service excellence award for his work responding to the COVID-19 pandemic. Dr. Menachemi is also the Fairbanks Endowed Chair, professor and health policy and management department chair at the Indiana University Richard M. Fairbanks School of Public Health.  

The iHEN service excellence award honors an individual who has demonstrated dedication in providing exceptional service to citizens and healthcare workers in Indiana. Recognized for his work on the Indiana prevalence study and other pandemic response activities, Dr. Menachemi and his team partnered with state and local officials and hospital executives to support real-time decisions made about the pandemic. In addition, the award acknowledged his leadership in training health administration and public health students in Indiana. 

“This award recognizes the hard work and sacrifices of our faculty and staff in response to the pandemic,” said Dr. Menachemi. “I am fortunate to work with a great set of colleagues both inside the Fairbanks School and within partner organizations around the state. From COVID-19 research and practice, to assuring the success of our students, each member of our faculty and staff has made an indelible mark on Indiana’s health in the last 18 months.” 

Related News

Nov 16, 2021 • News
Study tackles reducing bladder cancer recurrence
National and international guidelines call for administration of postoperative immediate chemotherapy to reduce recurrence of non-muscle invasive bladder cancer. Yet this is done in less than half of cases. A new study led by Clint Cary, M.D., MPH, of the Regenstrief Institute and Indiana University School of Medicine, explores environmental barriers to implementation of these…
Continue Reading >
Nov 15, 2021 • News
No FIT: Colon cancer screening FIT doesn’t belong in emergency and inpatient settings
FIT and other cancer screening tests not designed for diagnosis A clinical research study from Indiana University School of Medicine and the Regenstrief Institute examines the use, in emergency and inpatient settings, of FIT (fecal immunochemical testing), which looks for blood in stool, a possible sign of colorectal cancer. The researchers conclude that FIT should…
Continue Reading >